ESR1 and breast carcinoma: In a biological assay, three of the three cell line–based ER+ breast cancer xenografts (MCF7, T47D, and ZR75.1) tested grew significantly better in the novel humanized NSG-Pro strain compared to nonhumanized NSG mice (Fig. 1, H to J).